Treatment with Adalimumab ( DrugBank: Adalimumab )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
96クローン病2

96. クローン病


臨床試験数 : 2,442 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2017-004588-11-NL
(EUCTR)
10/09/201910/09/2019Control Crohn Safe Trial: Long term outcome and tolerability of six months adalimumab as initial treatment for newly diagnosed Crohn's disease versus standard step-up treatment.Control Crohn Safe Trial: Long term efficacy and safety of periodic treatment with adalimumab versus standard step-care for newly diagnosed Crohn's disease. - CoCroS trial The chronic inflammatory bowel disease Crohn's disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]Trade Name: HumiraUniversity MaastrichtNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
158Phase 4Netherlands
2NCT01144156
(ClinicalTrials.gov)
July 200713/6/2010Small Bowel Mucosal Healing Induced by Adalimumab in Crohn's Disease Patients as Assessed by Capsule EndoscopySmall Bowel Mucosal Healing Induced by Adalimumab in Crohn's Disease Patients as Assessed by Capsule EndoscopyCrohn's DiseaseDrug: Treatment with AdalimumabRabin Medical CenterAbbottNot yet recruiting18 YearsN/ABoth30N/AIsrael